sr 95531 has been researched along with 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one in 1 studies
Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one) | Trials (2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one) | Recent Studies (post-2010) (2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one) |
---|---|---|---|---|---|
610 | 0 | 209 | 184 | 0 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Babich, M; Branda, EM; Elfline, GS; Quock, RM | 1 |
1 other study(ies) available for sr 95531 and 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one
Article | Year |
---|---|
Antagonism by NOS inhibition of the behavioral effects of benzodiazepine and GABAA receptor agonists in the mouse elevated plus-maze.
Topics: Animals; Anxiety; Behavior, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; GABA Agonists; GABA-A Receptor Agonists; Injections, Intraventricular; Isoxazoles; Male; Mice; Nitric Oxide Synthase; Nitroarginine; Pyrazoles; Pyridazines | 2004 |